查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2013009

大肠镜设备市场：按组件、治疗领域和最终用户划分－2026-2032年全球市场预测

Colonoscopy Device Market by Component, Therapeutic Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年大肠镜设备市场价值为 23.8 亿美元，预计到 2026 年将成长至 25.7 亿美元，复合年增长率为 8.07%，到 2032 年将达到 41.1 亿美元。

主要市场统计数据
基准年 2025 23.8亿美元
预计年份：2026年 25.7亿美元
预测年份 2032 41.1亿美元
复合年增长率 (%) 8.07%

策略部署正在重塑全球大肠镜检查设备的部署，概述了临床需求、技术进步和护理路径的变化。

在临床需求、技术创新以及对患者疗效日益重视的推动下，大肠镜设备市场目前正经历重大变革。近年来，影像技术、人体工学和一次性耗材技术的进步，促使临床实践转向以诊断准确性和操作效率为优先的检查方法。同时，筛检模式也正在适应公共卫生需求，随着终端使用者寻求能够简化不同医疗机构工作流程的设备，连续性医疗服务也不断发展。

临床方案、影像技术和经营模式的进步，正在为大肠镜设备市场和医疗保健服务体系带来哪些结构性变化？

大肠镜设备在临床实践、技术发展和供应链结构等方面正经历重大变革，这些变革将全面重塑大肠镜设备的竞争格局。在临床方面，人们越来越重视预防医学和早期检测方案，这推动了对影像能力的投资，以提高病变的检出率和特征分析能力。同时，影像光学、感测器小型化和人工智慧影像分析方面的创新，为即时决策支援和提高手术精准度创造了新的可能性。

2025 年关税变化对大肠镜设备供应链的采购、製造地和采购韧性的多方面影响。

关税的引入和贸易政策的转变（将于2025年生效）对大肠镜设备的采购、製造和定价策略产生了复杂的连锁反应。对于进口成品或关键零件的公司而言，关税带来的成本增加迫使它们重新评估采购地点和供应商合约。一些製造商采取的因应措施包括：将生产设施迁至其他地区、重新设计供应链以降低关税风险，或协商长期采购合约以稳定投入成本。

基于可操作的细分洞察，使设备设计、服务模式和临床证据与组件、治疗领域和最终用户的多样化需求保持一致。

深入了解市场区隔对于在整个大肠镜市场中优先进行研发和商业化工作至关重要。按组件划分，该生态系统由「大肠镜设备」、「大肠镜配件」和「影像显示系统」组成，其中大肠镜设备可进一步细分为「光纤结肠镜」和「视讯大肠镜」。每个组件类别都有其独特的开发路径。光纤技术在某些传统应用中仍然至关重要，而视讯大肠镜由于影像品质的提升和整合功能的增强，正逐渐成为新投资的主流。配件是持续的收入来源，并影响整体拥有成本，而视觉化系统则日益成为增值软体和分析功能的平台。

我们透过提供可操作的区域洞察，帮助您制定业务扩大策略，这些洞察突显了美洲、欧洲、中东和非洲以及亚太地区在监管、还款和采用方面的细微差异。

区域趋势正在塑造美洲、欧洲、中东和非洲以及亚太地区在产品部署、监管沟通和商业性伙伴关係方面的不同策略重点。在美洲，已建立的筛检项目和简化流程的措施正在影响市场需求，推动对高解析度视觉化和工作流程优化能力的投资。该地区的监管路径要求提供强有力的临床证据和上市后监测，因此转化临床研究和真实世界数据 (RWE) 计画成为新参与企业和成熟企业的首要任务。

透过技术整合、以证据为基础的合作以及以服务为导向的商业化模式，企业层面的竞争力得以提升，从而实现长期差异化。

医疗设备製造商、影像专家和耗材供应商之间的竞争动态日益受到能力整合、证据产生和服务交付模式的影响。领先机构正投资于跨学科合作，将光学技术和软体分析相结合，从而提高诊断灵敏度，并支援临床路径和保险报销相关流程的记录。同时，小规模但高度专业化的创新者往往在一次性产品、易于消毒的设计或一次性光学元件方面取得突破性进展，直接应对感染控制的优先事项和营运限制。

为医疗设备製造商和医疗保健系统领导者提供具体而有影响力的建议，以使其产品设计、供应弹性和商业化与临床和经济优先事项保持一致。

产业领导者必须采取果断行动，透过协调产品开发、供应链策略和商业性执行，将颠覆性趋势转化为永续的竞争优势。应优先采用模组化设计方法，实现视觉化和分析功能的分阶段升级，而无需彻底更换设备，从而延长设备使用寿命，降低买家对资本投资的抵触情绪。同样重要的是，尽可能实现供应商多元化和近岸外包，以降低关税风险和物流瓶颈，同时确保品管和合规性。

对用于得出有关大肠镜设备的临床意义和商业性意义的研究结果的研究方法、资料来源和检验程序进行透明的解释。

这项高阶主管分析的研究结合了系统性的二手资料研究和有针对性的一手资料研究，以确保研究结果基于临床实践和实际操作情况。二级资讯来源包括同行评审的临床文献、监管文件和行业白皮书，旨在了解技术进步、安全考量和标准治疗方案。这些研究成果与对执业内视镜医师、采购经理和生物医学工程师的一手访谈进行了交叉比对，以收集关于可用性、培训需求和采购标准的实际观点。

简洁扼要的结论整合了策略重点和必要的权衡取舍，这些因素决定了大肠镜设备市场新产品上市的成功率和长期影响。

总而言之，大肠镜设备领域呈现出以下几个面向的融合趋势：临床对更高检测能力的需求、影像和分析技术的进步，以及采购趋势和政策变化带来的商业性调整。这些因素为产品差异化开闢了清晰的路径：卓越的可视化和整合分析能力能够创造临床价值；稳健的供应炼和本地化能力能够降低营运风险；循证服务模式能够获得保险公司和医疗服务提供者的支持。能够将产品创新与切实可行的部署策略和严格的临床检验相结合的相关人员，将更有能力影响标准诊疗流程，并确保在各种医疗环境中得到永续应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 大肠镜设备市场：依组件划分

  • 大肠镜检查装置
    • 纤维光学大肠镜检查
    • 视讯大肠镜检查
  • 大肠镜检查配件
  • 影像显示系统

第九章：大肠镜设备市场：依治疗领域划分

  • 结肠癌
  • 克隆氏症
  • 林奇症候群
  • 溃疡性大肠炎

第十章：大肠镜设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院
  • 研究所

第十一章 大肠镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 大肠镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章：大肠镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国大肠镜设备市场

第十五章：中国大肠镜设备市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Avantis Medical Systems
  • Boston Scientific Corporation
  • ColoWrap, LLC.
  • ConMed Corporation
  • Dantschke Medizintechnik GmbH & Co. KG
  • Endomed Systems GmbH
  • FUJIFILM Holdings Corporation
  • GI View Ltd
  • Getinge AB
  • Hologic, Inc.
  • HOYA Corporation
  • Huger Medical Instrument Co.,Ltd
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Olympus Corp.
  • Ottomed Endoscopy by Mitra Medical Services LLP
  • Pro Scope Systems LLC
  • Richard Wolf GmbH
  • SHAILI ENDOSCOPY PRIVATE LIMITED
  • Shanghai Shiyin Photoelectric Instrument Co.,Ltd.
  • Smith & Nephew Plc
  • Sonoscape Medical Corp
  • Steris Corporation
  • Stryker Corporation
Product Code: MRR-431B7BFFBF3C

The Colonoscopy Device Market was valued at USD 2.38 billion in 2025 and is projected to grow to USD 2.57 billion in 2026, with a CAGR of 8.07%, reaching USD 4.11 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.38 billion
Estimated Year [2026] USD 2.57 billion
Forecast Year [2032] USD 4.11 billion
CAGR (%) 8.07%

A strategic introduction outlining clinical imperatives, technological momentum, and care pathway changes that are reshaping colonoscopy device deployment worldwide

The landscape of colonoscopy devices is in the midst of a substantive transformation driven by clinical demand, technological innovation, and heightened emphasis on patient outcomes. Over recent years, advances in visualization, ergonomics, and disposable technologies have shifted clinical practice toward procedures that prioritize diagnostic accuracy and procedural efficiency. At the same time, the care continuum is evolving as screening paradigms adapt to population health imperatives and as end users seek devices that streamline workflows in diverse care settings.

Clinicians and procurement teams now expect devices that deliver superior imaging, reduced downtime, and enhanced infection control, while health systems weigh capital investment against throughput and long-term operational costs. Meanwhile, manufacturers face growing pressure to demonstrate clinical value through evidence generation and to design solutions that integrate with existing information systems. These intersecting forces create both opportunities and constraints that must be navigated with a clear grasp of clinical needs, regulatory expectations, and commercial realities.

In this context, the role of colonoscopy devices extends beyond instrumentation to include procedural protocols, training, and post-procedure data management. As such, stakeholders must consider not only the technology itself but also how devices interact with accessories, visualization systems, and end-user environments to deliver reliable clinical outcomes and sustainable service delivery models

How converging advances in clinical protocols, imaging technology, and commercial models are driving structural changes in colonoscopy device markets and care delivery

Significant shifts are underway across clinical practice, technology development, and supply chain configurations that collectively redefine competitive dynamics in colonoscopy devices. On the clinical front, there is an accelerating focus on preventive care and early detection protocols, prompting investment in imaging capabilities that improve lesion detection and characterization. Concurrently, innovations in video optics, sensor miniaturization, and AI-enabled image analysis are creating new possibilities for real-time decision support and enhanced procedural confidence.

From a commercial perspective, business models are evolving as manufacturers experiment with service-oriented offerings, bundled consumables, and hybrid capital-asset approaches that reduce upfront friction for buyers. Regulatory frameworks are adapting to these shifts, placing greater emphasis on post-market surveillance and cybersecurity for connected visualization systems. Moreover, buy-side behavior is changing: hospitals and outpatient centers increasingly favor devices that reduce turnover time and support standardized training pathways for staff.

These combined dynamics necessitate strategic choices around product portfolios, channel strategies, and evidence generation. In particular, the integration of digital tools and interoperability features represents a transformative axis, enabling better procedural analytics and extended value propositions. As a result, organizations that align clinical validation with pragmatic deployment strategies are positioned to capture long-term adoption and to influence standards of care across diverse clinical settings

The multifaceted consequences of 2025 tariff changes on procurement, manufacturing footprints, and procurement resilience across colonoscopy device supply chains

The introduction of tariffs and trade policy shifts that took effect in 2025 has produced complex ripple effects across procurement, manufacturing, and pricing strategies for colonoscopy devices. For organizations importing finished devices or key subcomponents, tariff-related cost increases compelled reassessment of sourcing footprints and supplier contracts. Some manufacturers responded by shifting production to alternative jurisdictions, by redesigning supply chains to reduce tariff exposure, or by negotiating longer-term procurement agreements to stabilize input costs.

Hospitals and ambulatory centers experienced indirect impacts through higher acquisition and consumable expenses, which in turn influenced capital expenditure planning and device replacement cycles. Procurement teams increasingly prioritized suppliers with localized production capabilities or with demonstrable resilience in logistics to avoid disruption. In addition, the tariffs elevated the importance of regulatory alignment and classification clarity, since reclassification of certain components or assemblies affected duty treatment and compliance costs.

Policy change also accelerated strategic conversations about nearshoring and vertical integration. Some firms pursued greater in-country assembly or component sourcing to mitigate tariff exposure and shorten lead times, thereby improving service responsiveness. Meanwhile, payer and provider negotiations reflected heightened scrutiny of total cost of care, prompting renewed emphasis on device durability, reprocessing efficiency, and procedural throughput as levers to offset higher upfront outlays. Overall, the 2025 tariff environment reinforced the need for agile commercial models, diversified supplier networks, and careful lifecycle cost analysis in procurement decision-making

Practical segmentation-driven insights that align device design, service models, and clinical evidence with differentiated needs across components, therapeutic areas, and end users

A granular understanding of segmentation is essential to prioritize development and commercialization efforts across the colonoscopy device landscape. By component, the ecosystem encompasses Colonoscope Devices, Colonoscopy Accessories, and Visualization Systems, with Colonoscope Devices further divided into Fiber-optic Colonoscopes and Video Colonoscopes. Each component category presents distinct development pathways: fiber-optic technology retains relevance in specific legacy applications while video colonoscopes dominate new investments due to improved imaging and integration capabilities. Accessories play a recurring revenue role and influence total cost of ownership, whereas visualization systems increasingly act as platforms for value-added software and analytics.

Across therapeutic areas, demand drivers vary according to clinical complexity and screening protocols, with Colorectal Cancer representing a primary focus for sensitivity and specificity improvements. Management of inflammatory bowel disease conditions such as Crohn's Disease and Ulcerative Colitis creates demand for devices that support therapeutic interventions and enhanced mucosal visualization, while genetic-risk monitoring for Lynch Syndrome emphasizes surveillance strategies and repeat-procedure considerations. These clinical distinctions shape product requirements, evidence generation priorities, and post-market support models.

End-user segmentation further refines market approach because adoption dynamics and procurement processes differ markedly across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Hospitals, and Research Laboratories. Ambulatory centers often prioritize throughput and simplified procedures, clinics may emphasize affordability and ease of use, diagnostic centers focus on specialized imaging and workflow optimization, hospitals balance capital investment with cross-department utility, and research laboratories require advanced customization and data capture. Tailoring product features, service models, and training to these differentiated needs is critical for successful commercialization and sustained utilization

Actionable regional insights highlighting regulatory, reimbursement, and adoption nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific to inform expansion strategies

Regional dynamics shape strategic priorities for product rollouts, regulatory engagement, and commercial partnerships in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Within the Americas, demand is influenced by established screening programs and a drive toward procedural efficiency, prompting investment in high-definition visualization and workflow-enhancing features. Regulatory pathways in the region require robust clinical evidence and post-market surveillance, making translational clinical studies and real-world evidence programs high priorities for new entrants and incumbents alike.

The Europe, Middle East & Africa region presents a heterogeneous environment where reimbursement frameworks and procurement processes vary significantly across national and subnational markets. In many parts of this region, public procurement mechanisms favor cost-effectiveness and lifecycle reliability, while some advanced care centers pursue cutting-edge imaging capabilities, creating a dual-track demand profile. Localization of service networks and training programs is often necessary to secure sustainable adoption in this complex regulatory and payer landscape.

Asia-Pacific is notable for rapid capacity expansion, growing adoption of outpatient and diagnostic center models, and a strong interest in cost-competitive innovations. Manufacturers frequently adapt product portfolios and pricing strategies to meet diverse economic conditions and heterogeneous clinical needs across the region. In each geography, partnerships with local distributors, investment in training, and alignment with regional regulatory expectations are essential levers for market entry and long-term performance

Competitive company-level dynamics driven by technology integration, evidence partnerships, and service-oriented commercialization models that determine long-term differentiation

Competitive dynamics among device manufacturers, imaging specialists, and consumables suppliers are increasingly defined by capability integration, evidence generation, and service delivery models. Leading organizations invest in cross-disciplinary collaborations that link optical engineering with software analytics, thereby enhancing diagnostic sensitivity and enabling procedural documentation that supports clinical pathways and reimbursement discussions. At the same time, smaller, focused innovators often drive disruptive advances in disposables, sterilization-friendly designs, or single-use optics that respond directly to infection control priorities and operational constraints.

Strategic partnerships between manufacturers and clinical research networks have become an important mechanism to generate the prospective clinical validation required by purchasers and regulators. Similarly, companies that offer end-to-end solutions-combining colonoscope hardware, visualization platforms, consumables, and training-create stronger value propositions for multi-site health systems seeking standardized protocols and predictable service outcomes. Transitioning from transactional sales to outcome-oriented contracts and bundled purchasing arrangements is emerging as a differentiator for firms that can demonstrate improved workflow efficiency and patient outcomes.

Capital markets and private equity interest have also influenced competitive behavior, providing growth capital for product development and market expansion while accelerating consolidation in particular subsegments. This environment rewards management teams that can articulate a clear path to clinical impact, scalable service operations, and resilient supply chains

Concrete, high-impact recommendations for device makers and health system leaders to align product design, supply resilience, and commercialization with clinical and economic priorities

Industry leaders must act decisively to translate disruptive trends into sustainable competitive advantage by aligning product development, supply chain strategy, and commercial execution. Prioritize modular design approaches that enable incremental upgrades to visualization and analytics without necessitating full instrument replacement, thereby extending device lifecycles and reducing buyer resistance to capital investment. Equally important is diversification of the supplier base and nearshoring where feasible to mitigate tariff exposure and logistical bottlenecks while preserving quality control and regulatory compliance.

Investing in rigorous clinical validation and real-world evidence programs will accelerate payer acceptance and support premium positioning based on demonstrable clinical benefits. Trainings and certification pathways for end users can reduce variability in procedural outcomes and strengthen value arguments for advanced imaging systems. From a commercial standpoint, experiment with flexible pricing models and outcome-linked contracts that share risk with purchasers and highlight total cost of care improvements rather than upfront cost alone.

Finally, build partnerships across healthcare ecosystems-including IT integrators, infection prevention leaders, and clinical training providers-to deliver holistic solutions that address workflow, safety, and data integration. These interdisciplinary collaborations will be instrumental in fostering adoption in diverse care settings and in unlocking long-term relationships with high-volume purchasers

A transparent description of research methods, data sources, and validation steps used to generate clinically grounded and commercially relevant colonoscopy device insights

The research underpinning this executive analysis combined systematic secondary research with targeted primary engagements to ensure findings are grounded in clinical practice and operational realities. Secondary sources included peer-reviewed clinical literature, regulatory documents, and industry white papers to map technological trajectories, safety considerations, and standard-of-care protocols. These insights were triangulated with primary interviews conducted with practicing endoscopists, procurement leaders, and biomedical engineers to capture frontline perspectives on usability, training needs, and purchasing criteria.

Qualitative analysis focused on thematic synthesis of clinical priorities and adoption barriers, while structured interviews provided comparative viewpoints on device performance, reprocessing workflows, and consumable management. Supply chain evaluations incorporated public trade data, vendor disclosures, and expert commentary to analyze sourcing risks and mitigation strategies. To validate conclusions, draft findings were reviewed with external clinical advisors and adjusted to reflect consensus on clinical utility, regulatory constraints, and operational feasibility.

Limitations of the methodology include variability in country-level reimbursement frameworks and the evolving nature of regulatory guidance for connected visualization systems. Nevertheless, integrating diverse data streams and expert validation supports robust, actionable insights for stakeholders seeking to make informed strategic choices in product development, market entry, and procurement planning

A concise conclusion synthesizing strategic priorities and the essential trade-offs that will determine successful adoption and long-term impact in colonoscopy device markets

In summary, the colonoscopy device arena is experiencing a convergence of clinical demand for improved detection, technological advances in imaging and analytics, and commercial adjustments driven by procurement dynamics and policy changes. These forces create distinct pathways to differentiation: superior visualization and integrated analytics produce clinical value, resilient supply chains and localized capabilities reduce operational risk, and evidence-based service models unlock payer and provider buy-in. Stakeholders who synchronize product innovation with pragmatic deployment strategies and rigorous clinical validation will be best positioned to influence standards of care and to secure durable adoption across diverse care settings.

The combined impact of tariffs, regulatory evolution, and shifting end-user priorities underscores the importance of agility and cross-functional collaboration. Whether addressing the specific needs of hospitals, ambulatory centers, diagnostic facilities, or research laboratories, successful organizations will align product, pricing, and training strategies to the operational realities of their target end users. Ultimately, a balanced approach that prioritizes clinical outcomes, total cost of care, and supply resilience will enable sustainable growth and meaningful improvements in patient care

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Colonoscopy Device Market, by Component

  • 8.1. Colonoscope Devices
    • 8.1.1. Fiber-optic Colonoscopes
    • 8.1.2. Video Colonoscopes
  • 8.2. Colonoscopy Accessories
  • 8.3. Visualization Systems

9. Colonoscopy Device Market, by Therapeutic Area

  • 9.1. Colorectal Cancer
  • 9.2. Crohn's Disease
  • 9.3. Lynch Syndrome
  • 9.4. Ulcerative Colitis

10. Colonoscopy Device Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals
  • 10.5. Research Laboratories

11. Colonoscopy Device Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Colonoscopy Device Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Colonoscopy Device Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Colonoscopy Device Market

15. China Colonoscopy Device Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Ambu A/S
  • 16.6. Avantis Medical Systems
  • 16.7. Boston Scientific Corporation
  • 16.8. ColoWrap, LLC.
  • 16.9. ConMed Corporation
  • 16.10. Dantschke Medizintechnik GmbH & Co. KG
  • 16.11. Endomed Systems GmbH
  • 16.12. FUJIFILM Holdings Corporation
  • 16.13. G.I. View Ltd
  • 16.14. Getinge AB
  • 16.15. Hologic, Inc.
  • 16.16. HOYA Corporation
  • 16.17. Huger Medical Instrument Co.,Ltd
  • 16.18. Karl Storz SE & Co. KG
  • 16.19. Medtronic PLC
  • 16.20. Olympus Corp.
  • 16.21. Ottomed Endoscopy by Mitra Medical Services LLP
  • 16.22. Pro Scope Systems LLC
  • 16.23. Richard Wolf GmbH
  • 16.24. SHAILI ENDOSCOPY PRIVATE LIMITED
  • 16.25. Shanghai Shiyin Photoelectric Instrument Co.,Ltd.
  • 16.26. Smith & Nephew Plc
  • 16.27. Sonoscape Medical Corp
  • 16.28. Steris Corporation
  • 16.29. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLONOSCOPY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLONOSCOPY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY FIBER-OPTIC COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY FIBER-OPTIC COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY FIBER-OPTIC COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VIDEO COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VIDEO COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VIDEO COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY LYNCH SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY LYNCH SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY LYNCH SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY ULCERATIVE COLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY ULCERATIVE COLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. GCC COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. GCC COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 99. GCC COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. G7 COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. G7 COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 114. G7 COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. NATO COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 118. NATO COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 119. NATO COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)